Read Me!
COMMIT Study for Metastatic Colorectal Cancer
EA2176 Trial for Metastatic Squamous Cell Anal Cancer
SUNLIGHT Study for Metastatic Colorectal Cancer
CIRCULATE-US Trial
ERASUR TRIAL
CORRECT-MRD II Trial
Questions? Feedback?

EA2176: Who is eligible to join?

Patients are eligible if they:

  1. Are 18 years are older
  2. Have recurrent or metastatic squamous cell carcinoma of the anal canal that cannot be surgically resected. Patients with HIV, HBV, and HCV are eligible

Patients are not eligible if they:

  • Have been previously treated with systemic chemotherapy or an investigational agent for the treatment of inoperable recurrent/metastatic disease
  • Have had prior treatment with immunotherapy
  • Have active autoimmune disease
  • Have history/evidence of interstitial lung disease

There are additional eligibility requirements for this study: see the complete list at clinicaltrials.gov. Contact your doctor if you are unsure of your eligibility. You can also contact a study doctor who will review the criteria with you and help determine your eligibility.